1.32Open2.95Pre Close81 Volume130 Open Interest77.00Strike Price5.27KTurnover1220.97%IV0.25%PremiumDec 13, 2024Expiry Date0.19Intrinsic Value100Multiplier0DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type0.5489Delta0.2260Gamma102.92Leverage Ratio-282.1316Theta0.0000Rho56.49Eff Leverage0.0006Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet